Deutsche Bank Ag\ Allakos Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Allakos Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 912,977 shares of ALLK stock, worth $858,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares

912,977

Previous 913,039 0.01%

Holding current value

$858,198

Previous $913,000 35.05%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.54 - $0.92 $33 - $57	-62 Reduced 0.01%	912,977 $593,000
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $27,772 - $40,269	-27,772 Reduced 2.95%	913,039 $913,000
Q1 2024 May 15, 2024	BUY	$1.02 - $3.23 $959,627 - $3.04 Million	940,811 New	940,811 $1.19 Million
Q3 2023 Nov 09, 2023	BUY	$2.13 - $5.55 $14,149 - $36,868	6,643 Added 23.53%	34,879 $79,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $101,649 - $148,239	28,236 New	28,236 $123,000
Q2 2022 Aug 11, 2022	SELL	$2.6 - $6.14 $73,663 - $173,958	-28,332 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.08 - $9.81 $20,899 - $40,358	4,114 Added 16.99%	28,332 $161,000
Q4 2021 Feb 11, 2022	SELL	$8.55 - $111.89 $329,046 - $4.31 Million	-38,485 Reduced 61.38%	24,218 $237,000
Q3 2021 Nov 04, 2021	SELL	$76.53 - $110.43 $1.71 Million - $2.47 Million	-22,378 Reduced 26.3%	62,703 $6.64 Million
Q2 2021 Aug 11, 2021	BUY	$85.37 - $114.1 $2.3 Million - $3.07 Million	26,925 Added 46.3%	85,081 $7.26 Million
Q1 2021 May 13, 2021	SELL	$109.73 - $153.66 $2.57 Million - $3.6 Million	-23,434 Reduced 28.72%	58,156 $6.68 Million
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $301,608 - $577,785	-3,790 Reduced 4.44%	81,590 $11.4 Million
Q3 2020 Nov 12, 2020	SELL	$66.43 - $90.99 $1.49 Million - $2.05 Million	-22,501 Reduced 20.86%	85,380 $6.96 Million
Q2 2020 Aug 13, 2020	BUY	$44.04 - $80.69 $4.16 Million - $7.63 Million	94,570 Added 710.47%	107,881 $7.75 Million
Q1 2020 May 14, 2020	SELL	$44.49 - $93.39 $296,080 - $621,510	-6,655 Reduced 33.33%	13,311 $593,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $919,157 - $1.9 Million	-13,824 Reduced 40.91%	19,966 $1.9 Million
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $667,027 - $1.93 Million	21,517 Added 175.32%	33,790 $2.66 Million
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $271,116 - $336,861	7,531 Added 158.81%	12,273 $530,000
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $67,140 - $103,304	1,987 Added 72.12%	4,742 $191,000
Q4 2018 Feb 14, 2019	SELL	$31.59 - $62.65 $506,703 - $1 Million	-16,040 Reduced 85.34%	2,755 $143,000
Q3 2018 Dec 21, 2021	BUY	$31.25 - $47.64 $68,250 - $104,045	2,184 Added 13.15%	18,795 $845,000
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $519,093 - $791,348	16,611 New	16,611 $745,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $79.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account